2. Signaling Pathways
  3. Membrane Transporter/Ion Channel
  4. Glycine Receptor (GlyR)
  5. Glycine Receptor (GlyR) Antagonist

Glycine Receptor (GlyR) Antagonist

Glycine Receptor (GlyR) Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-106969A
    ZD 9379 sodium
    		Antagonist
    ZD 9379 sodium is a competitive glycine/NMDA receptor antagonist, with an IC50 value of 75 nM (glutamate site). ZD 9379 sodium selectively antagonizes the glycine binding site (GlyB site) on the NMDA receptor, inhibiting the binding of glycine to the NMDA receptor and alleviating excitotoxicity. ZD 9379 sodium reduces the frequency of cortical spreading depression (SDs), alleviates energy depletion in the ischemic penumbra, and delays the expansion of infarction. ZD 9379 sodium reduces the infarct volume and improves neurological function in mouse models. ZD 9379 sodium can be used in studies of acute ischemic stroke, etc.